Salix Pharmaceuticals sues Novel over patent

Recs

0

Panic 2008... Profit 2009!

Fool -- Now's the time to invest! David and Tom Gardner's new book reveals their strategy for million dollar wealth.

Salix Pharmaceuticals Ltd. said Monday it filed a lawsuit against Novel Laboratories Inc. over its colonoscopy preparation tablet, OsmoPrep.

Salix said the lawsuit is in response to Somerset, N.J.-based Novel's application with the Food and Drug Administration to market a generic version of OsmoPrep before the patent expires in 2013. Salix filed the lawsuit in U.S. District Court for the District of New Jersey.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 723247, ~/articles/articlehandler.aspx, 1/7/2009 1:22:11 PM

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Jan 7 at 1:20 PM

Market Summary

DJIA 8,841.70 -173.40 -1.92%
S&P 500 914.17 -20.53 -2.20%
NASD 1,617.46 -34.92 -2.11%
Sponsored by:

Related Tickers

Salix Pharmaceuticals, Ltd.

CAPS Rating 3/5 Stars

$9.69

-0.01 (-0.10%)

Outperform76

Underperform16

Rate This Stock